These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 37384792

  • 41. "They have this not care - don't care attitude:" A Mixed Methods Study Evaluating Community Readiness for Oral PrEP in Adolescent Girls and Young Women in a Rural Area of South Africa.
    Nakasone SE, Chimbindi N, Mthiyane N, Nkosi B, Zuma T, Baisley K, Dreyer J, Pillay D, Floyd S, Birdthistle I, Seeley J, Shahmanesh M.
    AIDS Res Ther; 2020 Sep 07; 17(1):55. PubMed ID: 32894138
    [Abstract] [Full Text] [Related]

  • 42. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, Smit JA, Kimani J.
    J Int AIDS Soc; 2014 Sep 07; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [Abstract] [Full Text] [Related]

  • 43. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ, Mmema N, Dlamini V, Ciglenecki I, Mpala Q, Matse S, Kerschberger B, Wringe A.
    BMC Public Health; 2021 Apr 14; 21(1):727. PubMed ID: 33853575
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study.
    Ntinga X, Isehunwa OO, Msimango LI, Smith PM, Matthews LT, Van Heerden A.
    BMC Public Health; 2024 Feb 22; 24(1):553. PubMed ID: 38389039
    [Abstract] [Full Text] [Related]

  • 49. "I'm doing this test so I can benefit from PrEP": exploring HIV testing barriers/facilitators and implementation of pre-exposure prophylaxis among South African adolescents.
    Yoshioka E, Giovenco D, Kuo C, Underhill K, Hoare J, Operario D.
    Afr J AIDS Res; 2020 Jul 22; 19(2):101-108. PubMed ID: 32326813
    [Abstract] [Full Text] [Related]

  • 50. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, Jenkins S, Subedar H, Hoke T, Mullick S.
    PLoS One; 2020 Jul 22; 15(4):e0228620. PubMed ID: 32352969
    [Abstract] [Full Text] [Related]

  • 51. Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa.
    Bergam S, Harrison AD, Benghu N, Khumalo S, Tesfay N, Exner T, Miller L, Dolezal C, Hanass-Hancock J, Hoffman S.
    AIDS Behav; 2022 Sep 22; 26(9):2881-2890. PubMed ID: 35218452
    [Abstract] [Full Text] [Related]

  • 52. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).
    Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, Pathak S, Bekker LG, Swaminathan S, Stanton J, Farrior J, Sista N.
    J Int AIDS Soc; 2019 Oct 22; 22(10):e25408. PubMed ID: 31651098
    [Abstract] [Full Text] [Related]

  • 53. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
    Beesham I, Dovel K, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL.
    AIDS Behav; 2022 Sep 22; 26(9):3079-3087. PubMed ID: 35316471
    [Abstract] [Full Text] [Related]

  • 54. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H, Gomez GB, Kripke K, Barnabas RV, Watts C, Medley GF, Mukandavire Z.
    Sex Transm Dis; 2020 Nov 22; 47(11):767-777. PubMed ID: 33044426
    [Abstract] [Full Text] [Related]

  • 55. End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa.
    Brown MS, Hanif H, Little KM, Clark MR, Thurman AR, Flomen L, Doncel GF.
    BMC Infect Dis; 2022 Dec 08; 22(1):919. PubMed ID: 36482336
    [Abstract] [Full Text] [Related]

  • 56. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA.
    J Int AIDS Soc; 2022 May 08; 25(5):e25909. PubMed ID: 35543110
    [Abstract] [Full Text] [Related]

  • 57. "We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine." Factors influencing the choice of safer conception methods and experiences with its use: a qualitative study among HIV sero-discordant couples in Zimbabwe.
    Brown JM, Musara P, Gitome S, Chitukuta M, Mataveke B, Chirenda T, Mgodi N, Mutero P, Matubu A, Chareka G, Chasakara C, Murombedzi C, Makurumure T, Hughes CS, Bukusi E, Cohen CR, Shiboski S, Darbes L, Rutherford GW, Chirenje ZM, Mhlanga F.
    BMC Public Health; 2024 Jul 19; 24(1):1936. PubMed ID: 39030487
    [Abstract] [Full Text] [Related]

  • 58. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 59. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE, Harris TG, Chingombe I, Mapingure M, Mugurungi O, Rogers JH, Gozhora P, Wu Y, Samba C, Musuka G, Hakim AJ.
    J Int AIDS Soc; 2022 Feb 26; 25(2):e25873. PubMed ID: 35148029
    [Abstract] [Full Text] [Related]

  • 60. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important.
    Laher F, Salami T, Hornschuh S, Makhale LM, Khunwane M, Andrasik MP, Gray GE, Van Tieu H, Dietrich JJ.
    BMC Public Health; 2020 Nov 07; 20(1):1669. PubMed ID: 33160341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.